Results 11 to 20 of about 896,879 (225)

Prevalence of carbapenem-resistant Acinetobacter baumannii from 2005 to 2016 in Switzerland [PDF]

BMC Infectious Diseases, 2018
Background We describe the prevalence of invasive carbapenem-resistant Acinetobacter spp. isolated from 2005 to 2016 in different regions of Switzerland.
A. Ramette, A. Kronenberg, and the Swiss Centre for Antibiotic Resistance (ANRESIS)   +2 more
doaj   +6 more sources

Carbapenem-ResistantAcinetobacter baumannii [PDF]

Korean Journal of Clinical Microbiology, 2012
Clinical isolates of Acinetobacter spp. in Korea exhibit higher antimicrobial resistance rates than in foreign countries and frequently show multi-drug resistance. Approximately 67% (272/405) of Acinetobacter baumannii isolates collected from 19 hospitals in Korea in 2008 exhibited intermediate susceptibility or resistance to imipenem and/or meropenem.
Il Kwon Bae, Seok Hoon Jeong, Kyungwon Lee   +2 more
openaire   +2 more sources

Epidemiology of carbapenem resistant Acinetobacter baumannii in New Zealand

New Zealand Medical Journal, 2022
Carbapenem resistant Acinetobacter baumannii have limited treatment options and a propensity to cause hospital outbreaks. In recent years an increase in their detection has been observed in New Zealand. This study aimed to describe the molecular epidemiology of these isolates.This study utilised carbapenem resistant A.
Matthew R, Blakiston, Mark B, Schultz, Indira, Basu, Susan A, Ballard, Deborah, Williamson, Sally, Roberts   +5 more
openaire   +3 more sources

Molecular Identification of Carbapenem Resistance Acinetobacter baumannii causing Ventilator-Associated Pneumonia Isolated from Intensive Care Unit of Tertiary Care Hospital [PDF]

Journal of Pure and Applied Microbiology
Ventilator-associated pneumonia (VAP) is a serious complication in critically ill patients, significantly increasing morbidity and mortality. One concerning organism behind VAP is Acinetobacter baumannii, a multidrug-resistant bacterium has ability to ...
Vijeta Sharma, Rajni Sharma, Aruna Vyas
doaj   +2 more sources

Detection of OXA‐23 Among Carbapenem‐Resistant Acinetobacter baumannii Isolated From Intensive Care Units of a Tertiary Care Hospital in Pakistan [PDF]

MicrobiologyOpen
Carbapenem‐resistant Acinetobacter baumannii (CRAB) has been designated a top‐priority critical pathogen by the World Health Organization, and the CDC has also classified it as a serious and immediate public health threat.
Hafsa Waseem, Ihsan Ullah, Shahzad Ahmad, Irfan Ali Mirza, Benish Aleem, Shazia Iqbal   +5 more
doaj   +2 more sources

Prevalensi Gen OXA-23 pada Isolat Klinis Bakter Acinetobacter baumanii di RSUP Dr. M. Djamil Padang

Jurnal Ilmu Kesehatan Indonesia, 2021
Acinetobacter baumannii is such a big challenge in this modern era because of their multi-drug resistance (MDR) through their resistance mechanism, namely the production of beta lactamase enzymes, one of them is oxacillinases.
Mhd. Alzaref, Linosefa Linosefa, Gestina Aliska   +2 more
doaj   +1 more source

Prevalence and Impact on Mortality of Colonization and Super-Infection by Carbapenem-Resistant Gram-Negative Organisms in COVID-19 Hospitalized Patients

Viruses, 2023
Background: The relationship between superinfection by multidrug-resistant Gram-negative bacteria and mortality among SARS-CoV-2 hospitalized patients is still unclear.
Roberto Casale, Gabriele Bianco, Paulo Bastos, Sara Comini, Silvia Corcione, Matteo Boattini, Rossana Cavallo, Francesco Giuseppe De Rosa, Cristina Costa   +8 more
doaj   +1 more source

Global spread of carbapenem-resistant Acinetobacter baumannii [PDF]

Journal of Antimicrobial Chemotherapy, 2009
We have investigated the molecular epidemiology and distribution of carbapenemase genes in 492 imipenem-non-susceptible Acinetobacter baumannii worldwide isolates (North and Latin America, Europe, Asia, South Africa and Australia).MICs were determined by broth microdilution and Etest. The presence of carbapenemase-encoding genes was investigated by PCR.
Paul G, Higgins, Cathrin, Dammhayn, Meredith, Hackel, Harald, Seifert   +3 more
openaire   +3 more sources

Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology [PDF]

Clinical Microbiology and Infection, 2006
The increasing trend of carbapenem resistance in Acinetobacter baumannii worldwide is a concern since it limits drastically the range of therapeutic alternatives. Metallo-beta-lactamases (VIM, IMP, SIM) have been reported worldwide, especially in Asia and western Europe, and confer resistance to all beta-lactams except aztreonam.
Poirel, L., Nordmann, P.
openaire   +2 more sources

A global view on carbapenem-resistant Acinetobacter baumannii

mBio, 2023
ABSTRACT To give an update on the molecular epidemiology and global distribution of carbapenemase encoding genes, we subjected 313 carbapenem-resistant Acinetobacter baumannii isolated from 114 study centers in 47 countries in five world regions, Africa, Asia, Europe, Latin America, and North America, to ...
Carina Müller, Sandra Reuter, Julia Wille, Kyriaki Xanthopoulou, Danuta Stefanik, Hajo Grundmann, Paul G. Higgins, Harald Seifert   +7 more
openaire   +4 more sources